In line with these observations, it was reported that tumour-reactive CD4 T cells with tumoricidal activities expand in vivo and eradicate established melanoma after the transfer of naïve CD4 T cells into lymphopenic hosts (64). This evidence concerns the gene CD4 and neoplasm.